Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNAseq on APAP, APAP+MSC, APAP+HDF at 24h

ABSTRACT: RNAseq on APAP, APAP+MSC, APAP+HDF at 24h

PROVIDER: PRJNA814326 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18284673_1.fastq.gz	Fastqsanger.gz
	SRR18284673_2.fastq.gz	Fastqsanger.gz
	SRR18284674_1.fastq.gz	Fastqsanger.gz
	SRR18284674_2.fastq.gz	Fastqsanger.gz
	SRR18284675_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

RNAseq on APAP, APAP+MSC, APAP+HDF at 24h

Project description:RNAseq of liver homogenate 24h after APAP (300mg/kg) exposure followed by either MSC or HDF at 90 min. MSCs, not HDFs, ameliorate APAP-induced liver injury.

2022-09-16 | GSE198277 | GEO

RNAseq on APAP mice flow sorted macrophages at 72h

Project description:RNAseq of flow sorted macrophages 72h after APAP. Cxcr4 expression induced on subpopulation of macrophages after APAP.

2022-05-31 | GSE199249 | GEO

RNAseq on Human APAP-ALF

Project description:RNAseq on Human APAP-ALF

| PRJNA1076506 | ENA

RNAseq on Human APAP-ALF

Project description:Fifty percent of all acute liver failure (ALF) cases in the United States are due to acetaminophen (APAP) overdose. Assessment of canonical features of liver injury, such as plasma alanine aminotransferase activities are poor predictors of acute liver failure (ALF), suggesting the involvement of additional mechanisms independent of hepatocyte death. Previous work demonstrated a severe overdose of APAP results in impaired regeneration, the induction of senescence by p21, and increased mortality. We hypothesized that a discrete population of p21+ hepatocytes acquired a secretory phenotype that directly impedes liver recovery after a severe APAP overdose. Leveraging in-house human APAP explant liver and publicly available singlenuclei RNAseq data, we identified a subpopulation of p21+ hepatocytes enriched in a unique secretome of factors, such as Cxcl14. Spatial transcriptomics in the mouse model of APAP overdose confirmed the presence of a p21+ hepatocyte population that directly surrounded the necrotic areas. In both male and female mice, we found a dose-dependent induction of p21 and persistent circulating levels of the p21-specific constituent, Cxcl14, in the plasma after a severe APAP overdose. In parallel experiments, we targeted either the putative senescent hepatocytes with the senolytic drugs, dasatinib and quercetin, or Cxcl14 with a neutralizing antibody. We found that targeting Cxcl14 greatly enhanced liver recovery after APAP-induced liver injury, while targeting the senescent hepatocyte had no effect. This data supports that the sustained induction of p21 in hepatocytes with persistent Cxcl14 secretion are critical mechanistic events leading to ALF in mice and human patients.

2024-04-15 | GSE255777 | GEO

3'mRNA sequencing of hepatic RNA (MACE) at the time points 24h/48h after acetaminophen (APAP) (300mg/kg) administration

Project description:Hepatic RNA specimens from mice (C57BL/6) of the 4 groups (vehicle-treated at 24h/48h, n=6; acetaminophen (APAP)-treated (300mg/kg) at 24h/48h, n=7) were pooled at equal shares. Thereafter, pooled RNA underwent analysis by 3'mRNA sequencing (MACE, GenXPro, Frankurt, Germany).

2021-12-31 | GSE169071 | GEO

RNAseq on APAP mice flow sorted macrophages at 72h

Project description:RNAseq on APAP mice flow sorted macrophages at 72h

| PRJNA819060 | ENA

EV-derived miR-186-5p alleviates APAP-induced liver injury by the suppression of CXCL1

Project description:Acetaminophen (APAP) overdose is the major cause of drug-induced liver injury (DILI) and acute liver failure (ALF), and patients with advanced APAP toxicity rarely benefit from N-acetylcysteine (NAC), which is the first-line agent used in the clinic. Mesenchymal stromal cells (MSCs) and their extracellular vesicles (MSC-EVs) have shown promising effects in the treatment of DILI by decreasing neutrophil infiltration. However, the specific mechanism underlying the therapeutic effects of MSCs or MSC-EVs still needs to be elucidated. In this study, by using RNA-seq, we found that CXCL1, which is a chemoattractant for neutrophils, is a key molecule in MSC-mediated amelioration of DILI, and by luciferase reporter assay, we verified that MSC-EV-derived miR-186-5p binds to the 3’-UTR of CXCL1 to inhibit its expression in hepatocytes. Neutralizing CXCL1 reduces APAP-induced liver damage in vivo, and the agomir miR-186-5p shows excellent potential in the treatment of DILI. Overall, these findings suggest that the use of MSC-EVs may be a promising novel strategy for preventing DILI and that targeting the miR-186-5P/CXCL1 axis is a feasible approach for improving the efficacy of MSCs in the treatment of DILI.

2024-11-13 | GSE252192 | GEO

Gene expression profiles of TiPS, HDF-iPS, ES and T cells

Project description:To show the similarity among TiPSCs, HDF-iPSCs and ESCs and the differences between TiPSCs and T cells, this experiment was designed. Undifferentiated TiPSCs, HDF-iPSCs and ESCs were collected. And stimulated peripheral circulating terminally differentiated T cells were collected. Then, they were applied in this experiment.

2010-06-16 | E-GEOD-22088 | biostudies-arrayexpress

Transcription profiling of rat blood and liver exposed to acetaminophen (APAP)

Project description:This SuperSeries is composed of the following subset Series:; GSE5593: Acetaminophen (APAP) Rat Blood Training Gene Expression Data Set; GSE5594: Acetaminophen (APAP) Rat Blood Test Gene Expression Data Set; GSE5595: Acetaminophen (APAP) Rat Liver Test Gene Expression Data Set; The Supplementary files (appended below) contain the mapping for the decoding of blinded samples. Experiment Overall Design: Refer to individual Series

2008-06-14 | E-GEOD-5652 | biostudies-arrayexpress

Gene expression profiles of TiPS, HDF-iPS, ES and T cells

Project description:To show the similarity among TiPSCs, HDF-iPSCs and ESCs and the differences between TiPSCs and T cells, this experiment was designed.

2010-06-03 | GSE22088 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data